In a new study, researchers found that the inflammation behind painful episodes in sickle cell disease are correlated with ...

A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual ...

Variations in inflammation may contribute to vaso-occlusive events (VOEs) during the menstrual cycles of women with SCD, per a study.

For adults with sickle cell disease (SCD), C-reactive protein (CRP) levels increase significantly during the follicular phase of the menstrual cycle, according to a study published online April 9 in ...

Period-driven inflammation could influence the risk of pain events among women with sickle cell disease. Levels of C-reactive ...

A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual cycle in female patients with sickle cell disease (SCD), according to ...

Recursion Pharmaceuticals, a trailblazing TechBio company, has made a significant stride in the realm of oncology by dosing the first patient in its Phase 1 clinical trial for a potential B-cell ...

Wyatt McDonnell of Infinimmune shares insight on human-first models and what the FDA's policy shift means for biotech R&D.

A phase 1 open-label trial is underway, evaluating the safety and efficacy of CT-95 in patients with mesothelin-expressing ...

Researchers sought to determine whether mosunetuzumab would have long-term efficacy in patients with follicular lymphoma.